Wolverine Trading, LLC Novo Nordisk A S Put Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Put Options

26 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$119.07 - $145.42 $7.01 Million - $8.57 Million
58,900 Added 37.49%
216,000 $25.7 Million
Q2 2024

Aug 14, 2024
SELL
$122.71 - $146.91 $110,439 - $132,219
-900 Reduced 0.57%
157,100 $22.4 Million
Q1 2024

May 15, 2024
BUY
$102.11 - $135.92 $4.06 Million - $5.41 Million
39,800 Added 33.67%
158,000 $20.3 Million
Q4 2023

Feb 14, 2024
SELL
$87.78 - $105.45 $5.07 Million - $6.1 Million
-57,800 Reduced 32.84%
118,200 $12.2 Million
Q3 2023

Nov 15, 2023
BUY
$90.94 - $199.54 $11.3 Million - $24.7 Million
123,900 Added 237.81%
176,000 $16 Million
Q2 2023

Aug 23, 2023
BUY
$155.98 - $172.65 $5.74 Million - $6.35 Million
36,800 Added 240.52%
52,100 $8.43 Million
Q1 2023

May 15, 2023
SELL
$132.34 - $159.14 $3.76 Million - $4.52 Million
-28,400 Reduced 64.99%
15,300 $2.42 Million
Q4 2022

Feb 14, 2023
BUY
$102.55 - $135.33 $3.32 Million - $4.38 Million
32,400 Added 286.73%
43,700 $5.91 Million
Q3 2022

Nov 14, 2022
BUY
$95.28 - $116.93 $1.08 Million - $1.32 Million
11,300 New
11,300 $1.13 Million
Q2 2022

Aug 15, 2022
SELL
$103.24 - $121.81 $619,440 - $730,860
-6,000 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$93.1 - $112.54 $1.31 Million - $1.59 Million
-14,100 Reduced 70.15%
6,000 $675,000
Q4 2021

Feb 14, 2022
BUY
$95.88 - $117.08 $546,516 - $667,356
5,700 Added 39.58%
20,100 $2.24 Million
Q3 2021

Nov 12, 2021
BUY
$84.42 - $106.62 $818,874 - $1.03 Million
9,700 Added 206.38%
14,400 $1.38 Million
Q1 2021

May 14, 2021
BUY
$67.06 - $75.82 $315,182 - $356,353
4,700 New
4,700 $319,000
Q3 2020

Nov 13, 2020
SELL
$63.69 - $70.22 $1.39 Million - $1.54 Million
-21,900 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$58.54 - $67.94 $1.28 Million - $1.49 Million
21,900 New
21,900 $1.44 Million
Q1 2020

May 11, 2020
SELL
$49.46 - $64.78 $2.06 Million - $2.69 Million
-41,600 Closed
0 $0
Q4 2019

Feb 12, 2020
SELL
$49.86 - $58.26 $69,804 - $81,564
-1,400 Reduced 3.26%
41,600 $2.4 Million
Q3 2019

Nov 14, 2019
BUY
$47.54 - $53.43 $632,282 - $710,619
13,300 Added 44.78%
43,000 $2.22 Million
Q2 2019

Aug 20, 2019
BUY
$46.79 - $52.47 $159,086 - $178,398
3,400 Added 12.93%
29,700 $1.52 Million
Q1 2019

May 15, 2019
SELL
$46.36 - $52.63 $815,936 - $926,288
-17,600 Reduced 40.09%
26,300 $1.38 Million
Q4 2018

Feb 14, 2019
BUY
$41.54 - $47.25 $216,008 - $245,700
5,200 Added 13.44%
43,900 $2.01 Million
Q3 2018

Nov 14, 2018
BUY
$46.76 - $51.24 $827,652 - $906,948
17,700 Added 84.29%
38,700 $1.82 Million
Q1 2018

May 15, 2018
BUY
$48.49 - $58.14 $1.02 Million - $1.22 Million
21,000 New
21,000 $1.03 Million
Q4 2017

Feb 14, 2018
SELL
$47.53 - $53.73 $808,010 - $913,410
-17,000 Closed
0 $0
Q3 2017

Nov 15, 2017
BUY
$41.15 - $49.22 $699,550 - $836,740
17,000
17,000 $819,000

Others Institutions Holding NVO

# of Institutions
1,952
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email